Last updated: 2026-09-21 04:57:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AtaiBeckley Inc. (ATAI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.36, with a market capitalization of $2.73B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.27 to $7.45. This page covers its latest market performance, valuation, price trends and company information.
$2.73B | |
$7.31 | |
$22.91 | |
$0.82 | |
$7.29 | |
8.79M | |
14.37M | |
-- | |
$7.45 | |
$3.27 | |
-- | |
-- |
AtaiBeckley Inc. (ATAI) last closed at $7.29 as of 2026-09-10 23:49:00, unchanged from the previous close of $7.29.
During the latest regular trading session, ATAI traded between $0.82 and $22.91, with a volume of 8.79M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, AtaiBeckley Inc. (ATAI) moved from $7.34 to $7.36, representing a gain of 0.20% ($0.02).
The stock traded between $7.23 and $7.43 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 26.92 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 97.7%
ATAI is currently trading at $7.36, placing it 97.7% of the way from its 52-week low of $3.27 to its 52-week high of $7.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 99 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AtaiBeckley Inc. (ATAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.